Activist Chelsea Manning speaks when departing from the arraignment of UHC CEO accused murderer Luigi Mangione at Federal Court in New York City on Friday, April 25, 2025. Luigi Mangione plead not guilty to federal charges in killing of UnitedHealthcare CEO Brian Thompson who was shot and killed in midtown Manhattan in a targeted attack as he was about to attend the company s annual investor conference. NYP20250425138 JOHNxANGELILLO

Activist Chelsea Manning speaks when departing from the arraignment of UHC CEO accused murderer Luigi Mangione at Federal Court in New York City on Friday, April 25, 2025. Luigi Mangione plead not guilty to federal charges in killing of UnitedHealthcare CEO Brian Thompson who was shot and killed in midtown Manhattan in a targeted attack as he was about to attend the company s annual investor conference. NYP20250425138 JOHNxANGELILLO

Choose your license

Rights Managed:

One-time editorial use in an online article, social media channels, internal presentation, website, newsletter, or blog.

One-time editorial use in a book, newspaper or magazine (excluding cover page), external presentation. Limited to 5,000 circulation. This includes the rights available in the Standard license.

Media Info

Credit: UPI Photo

Media ID:

Recording Date: Apr 25, 2025

Media Size: 4,000×2,674 Pixels

Activist Chelsea Manning speaks when departing from the arraignment of UHC CEO accused murderer Luigi Mangione at Federal Court in New York City on Friday, April 25, 2025. Luigi Mangione plead not guilty to federal charges in killing of UnitedHealthcare CEO Brian Thompson who was shot and killed in midtown Manhattan in a targeted attack as he was about to attend the company s annual investor conference. NYP20250425138 JOHNxANGELILLO

Restrictions: This image can not be published in United States.

Release Info: Do I need a release?

Captions may have been translated or enriched by an AI system.
For more information about AI-assisted captions, see AI-assisted captions.

Need a custom license?

If your intended use isn't covered by the available options (such as non-editorial purposes or specific distribution needs), contact us. Our team will be happy to provide a tailored offer based on your requirements.